Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Ghana halts Ebola vaccine trial due to community protests

Published 11/06/2015, 00:18
Ghana halts Ebola vaccine trial due to community protests
JNJ
-

ACCRA (Reuters) - Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.

The country's Food and Drugs Authority said it had begun enlisting volunteers in Hohoe in the Volta region to be injected with drugs made by Johnson & Johnson (NYSE:JNJ) and Bavarian Nordic as part of a global Ebola vaccine drive.

Youth leaders threatened to boycott the programme. "We don't want to be guinea pigs," one local leader told Reuters.

Ebola has killed more than 11,000 people in Guinea, Sierra Leone and Liberia since it began more than a year ago but new cases have declined sharply. Ghana has yet to record a case.

"The (health) minister has suspended the trials indefinitely because the people said they don't want it," Health Ministry spokesman Tony Goodman said. The worst-hit countries have completed first trials of an experimental vaccine.

On Wednesday, parliament ordered the trials suspended and summoned the health minister to appear next week on the matter, senior parliamentary official Ebenezer Dzietror told Reuters.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.